Why the study?
To explore the feasibility of continuous low-dose isoproterenol to identify AF triggers under conscious sedation and examine the link between unmappable triggers and postablation recurrence.
Does protocolized isoproterenol provocation to identify and ablate triggers improve postablation recurrence rates in patients with paroxysmal atrial fibrillation?
Does protocolized isoproterenol provocation to identify and ablate triggers improve postablation recurrence rates in patients with paroxysmal atrial fibrillation?
Continuous low-dose isoproterenol provocation during PAF ablation identifies patients with unmappable triggers who are at a significantly higher risk of AF recurrence.
Answers are grounded in this paper and cite their sources.
Patients with unmappable triggers may have elevated recurrence risk; this Level 3 cohort finding leaves open whether isoproterenol provocation improves PAF ablation outcomes.
Objective To explore the feasibility of continuous low‐dose isoproterenol (ISP) in identifying atrial fibrillation (AF) triggers under conscious sedation and to investigate the association between unmappable triggers and postablation recurrence. Methods In 50 PAF patients (Group 1), standardized ISP infusion (2–4 μg/min) was administered to provoke triggers, followed by adenosine triphosphate (ATP) challenge (30–40 mg) if no arrhythmia was induced. A matched control cohort ( n = 96, Group 2) was selected based on baseline characteristics. Pulmonary vein isolation (PVI) was performed in all patients. Those with mappable triggers underwent additional ablation based on triggers. Additional ablation for other patient was guided by operators’ discretion. Results In Group 1, provocative testing identified mappable triggers in 35 patients (Group 1A: 34 PV triggers and 10 non‐PV triggers) and unmappable triggers in 5 (Group 1B), with 10 patients showing no inducible arrhythmia (Group 1C). After 12‐month follow‐up, Group 1B showed significantly higher recurrence than all other groups (60.0% vs. Group 1A: 5.7%, Group 1C: 0%, and Group 2: 14.6%; p < 0.05). Conclusions Continuous low‐dose ISP challenge provides a pragmatic approach for intraprocedural AF trigger identification, particularly under conscious sedation. The high recurrence rate in patients with unmappable triggers underscores the imperative for advanced mapping modalities to precisely localize arrhythmogenic foci origins.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: